LeadStory

CBC News

Canada approves drug to treat postpartum depression

CBC News · Just In
CBC News
CBC News
Just In

WARNING: Video contains discusssion of suicide | Health Canada has approved the first drug meant to specifically treat postpartum depression. The medication is designed to treat moderate to severe cases and can help relieve symptoms in as few as three days.

Breakdown
  • Zoranolone is the first drug approved in Canada for postpartum depression
  • Postpartum depression affects about one in five women after childbirth 14s
  • Clinical trials showed 27% had no depressive symptoms by day 15 1m 22s
  • Zoranolone was generally well tolerated but may decrease alertness 1m 35s
  • The drug is expected in Canada next year; cost is still unknown 2m 6s